GlassScriptPhysician profile
Shanti M Akers
NPI 1649409426
$8,130.93
in general payments reported to CMS, 2019-2025
36 companies · $867 in 2025
The $867 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,075 · 2020: $704 · 2021: $615 · 2022: $381 · 2023: $870 · 2024: $3,619 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839 · Education: $2,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,839.06 |
| Education | $2,517.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,616.34 | 2024 | |
| Glaxosmithkline, LLC. | $1,512.02 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $439.01 | 2019-2025 | Tyvaso, Tyvaso, Remodulin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.71 | 2019-2025 | Ofev, Jascayd |
| Janssen Pharmaceuticals, INC | $352.63 | 2020-2024 | Xarelto |
| Abiomed | $293.05 | 2023-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $276.02 | 2019-2023 | Uptravi, Opsumit |
| Sunovion Pharmaceuticals INC. | $274.68 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $231.25 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Pulmonx Corporation | $224.72 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Genzyme Corporation | $184.54 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $174.99 | 2020-2025 | Winrevair |
| Regeneron Healthcare Solutions, INC. | $136.36 | 2019-2025 | Dupixent |
| Insmed, INC. | $122.08 | 2020-2025 | Brinsupri |
| Genentech USA, INC. | $112.40 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $85.60 | 2022-2024 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $82.37 | 2020-2025 | Hyqvia |
| Bayer Healthcare Pharmaceuticals INC. | $79.98 | 2024-2025 | |
| Tactile Systems Technology INC | $58.02 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Abbott Laboratories | $57.57 | 2019 | |
| Grifols USA, LLC | $52.24 | 2021-2023 | Prolastin-C Liquid |
| Pfizer INC. | $51.15 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $35.94 | 2020-2024 | |
| Inspire Medical Systems, INC. | $34.94 | 2025 | Inspire |
| Alexion Pharmaceuticals, INC. | $34.19 | 2020-2022 | |
| Csl Behring | $30.65 | 2025 | Hizentra |
| Verona Pharma, INC. | $28.55 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $26.86 | 2024 | Acthar |
| Axsome Therapeutics, INC. | $23.35 | 2023 | Sunosi |
| Boston Scientific Corporation | $20.89 | 2023 | Rezum Generator |
| Mylan Specialty L.P. | $20.07 | 2019 | |
| Harmony Biosciences LLC | $19.07 | 2022 | |
| Novo Nordisk INC | $17.28 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.53 | 2020 | |
| Astellas Pharma US INC | $14.65 | 2019 | |
| Medtronic, INC. | $14.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanti Akers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.